Form 8-K - Current report:
SEC Accession No. 0001493152-24-002729
Filing Date
2024-01-17
Accepted
2024-01-17 16:30:31
Documents
12
Period of Report
2024-01-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39717
  Complete submission text file 0001493152-24-002729.txt   214675

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE mira-20240115.xsd EX-101.SCH 3048
3 XBRL LABEL FILE mira-20240115_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE mira-20240115_pre.xml EX-101.PRE 22381
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3428
Mailing Address 324 SOUTH HYDE PARK AVENUE, SUITE 350 TAMPA FL 33606
Business Address 855 N WOLFE STREET #623-6 BALTIMORE MD 21205 813-369-5150
MIRA PHARMACEUTICALS, INC. (Filer) CIK: 0001904286 (see all company filings)

EIN.: 853354547 | State of Incorp.: FL
Type: 8-K | Act: 34 | File No.: 001-41765 | Film No.: 24538812
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)